Analysis Article • Mar 27
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedMay 16, 2026
DataAggregated Company Financials
Companies376
- 7D-4.1%
- 3M-14.6%
- 1Y18.5%
- YTD-9.4%
Over the last 7 days, the Healthcare industry has dropped 4.1%, driven by Samsung BiologicsLtd declining 3.6%. On the other hand ALTEOGEN is actually up 8.4%. Over the past 12 months, the industry was up 19%. As for the next few years, earnings are expected to grow by 30% per annum.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 16 May 2026 | ₩339.6t | ₩64.6t | ₩1.9t | 20x | 174.2x | 5.3x |
| Mon, 13 Apr 2026 | ₩362.8t | ₩65.9t | ₩1.6t | 19x | 228.1x | 5.5x |
| Wed, 11 Mar 2026 | ₩381.9t | ₩61.0t | ₩2.7t | 17.5x | 139.1x | 6.3x |
| Fri, 06 Feb 2026 | ₩386.5t | ₩60.9t | ₩2.7t | 19x | 143.2x | 6.3x |
| Sun, 04 Jan 2026 | ₩369.1t | ₩61.9t | ₩2.7t | 19.1x | 136.5x | 6x |
| Tue, 02 Dec 2025 | ₩359.3t | ₩62.0t | ₩2.8t | 19.2x | 128.2x | 5.8x |
| Thu, 30 Oct 2025 | ₩323.3t | ₩60.3t | ₩2.1t | 20.3x | 156.3x | 5.4x |
| Sat, 27 Sep 2025 | ₩299.5t | ₩60.1t | ₩1.9t | 20.8x | 154.7x | 5x |
| Mon, 25 Aug 2025 | ₩288.1t | ₩59.6t | ₩2.0t | 21.5x | 143x | 4.8x |
| Wed, 23 Jul 2025 | ₩299.4t | ₩58.3t | ₩1.5t | 22.7x | 205.6x | 5.1x |
| Fri, 20 Jun 2025 | ₩275.6t | ₩57.8t | ₩1.6t | 21.7x | 172.1x | 4.8x |
| Sun, 18 May 2025 | ₩261.8t | ₩56.2t | ₩1.3t | 18.7x | 194.6x | 4.7x |
| Tue, 15 Apr 2025 | ₩267.0t | ₩56.1t | ₩1.3t | 18.2x | 202.9x | 4.8x |
| Thu, 13 Mar 2025 | ₩274.7t | ₩55.0t | ₩892.2b | 15.3x | 307.9x | 5x |
| Sat, 08 Feb 2025 | ₩282.5t | ₩54.6t | ₩831.2b | 14.8x | 339.9x | 5.2x |
| Mon, 06 Jan 2025 | ₩259.6t | ₩54.6t | ₩808.0b | 14.1x | 321.2x | 4.8x |
| Wed, 04 Dec 2024 | ₩254.9t | ₩54.4t | ₩787.5b | 14x | 323.7x | 4.7x |
| Fri, 01 Nov 2024 | ₩274.2t | ₩53.3t | ₩854.8b | 15.9x | 320.7x | 5.1x |
| Sun, 29 Sep 2024 | ₩267.9t | ₩53.4t | ₩856.0b | 17.1x | 313x | 5x |
| Tue, 27 Aug 2024 | ₩267.1t | ₩53.3t | ₩949.5b | 15.4x | 281.3x | 5x |
| Thu, 25 Jul 2024 | ₩254.7t | ₩52.3t | ₩750.8b | 16.6x | 339.2x | 4.9x |
| Sat, 22 Jun 2024 | ₩228.9t | ₩53.0t | ₩757.3b | 16.4x | 302.2x | 4.3x |
| Mon, 20 May 2024 | ₩233.0t | ₩52.4t | ₩915.6b | 18.5x | 254.4x | 4.4x |
| Wed, 17 Apr 2024 | ₩229.2t | ₩52.3t | ₩524.3b | 17.7x | 437.1x | 4.4x |
| Fri, 15 Mar 2024 | ₩240.3t | ₩52.2t | ₩87.8b | 20.6x | 2735.6x | 4.6x |
| Sun, 11 Feb 2024 | ₩220.1t | ₩52.0t | -₩55,498,881,746.00 | 21.3x | -3966.1x | 4.2x |
| Tue, 09 Jan 2024 | ₩228.7t | ₩56.1t | ₩268.5b | 23.3x | 851.8x | 4.1x |
| Thu, 07 Dec 2023 | ₩208.1t | ₩56.1t | ₩284.8b | 21.8x | 730.7x | 3.7x |
| Sat, 04 Nov 2023 | ₩199.5t | ₩56.0t | ₩1.0t | 18x | 194.5x | 3.6x |
| Mon, 02 Oct 2023 | ₩205.1t | ₩56.0t | ₩1.0t | 18.7x | 200.4x | 3.7x |
| Wed, 30 Aug 2023 | ₩214.1t | ₩55.9t | ₩1.0t | 23x | 205.3x | 3.8x |
| Fri, 28 Jul 2023 | ₩207.7t | ₩56.1t | ₩2.1t | 20.5x | 98.7x | 3.7x |
| Sun, 25 Jun 2023 | ₩209.4t | ₩56.3t | ₩2.1t | 20.4x | 99.4x | 3.7x |
| Tue, 23 May 2023 | ₩217.0t | ₩58.4t | ₩3.3t | 20.5x | 65.3x | 3.7x |
Price to Earnings Ratio
65.3x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 174x which is lower than its 3-year average PE of 289x.
- The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 16% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | -0.64% | |
| Healthcare | -4.06% | |
| Life Sciences | -2.87% | |
| Pharma | -3.23% | |
| Healthtech | -4.24% | |
| Biotech | -4.31% | |
| Medical Equipment | -6.71% | |
| Healthcare Services | -11.13% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 81.9x.
- Analysts are expecting annual earnings growth of 21.0%, which is higher than its past year's earnings decline of 29.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 46% over the next 5 years.
- This is better than its past earnings growth rate of 3.2% per year.
- In contrast, the Healthtech industry is expected to see its earnings decline by 38% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A196170 ALTEOGEN | ₩369.00k | 8.4% +₩1.5t | 16.2% | PE139.4x | |
| A128940 Hanmi Pharm | ₩472.50k | 8.4% +₩462.8b | 61.3% | PE35.3x | |
| A096530 Seegene | ₩31.05k | 27.3% +₩306.7b | 0.3% | PE29.7x | |
| A328130 Lunit | ₩18.29k | -7.5% ₩202.5b | -24.2% | PS16.4x | |
| A141080 LigaChem Biosciences | ₩191.40k | 2.3% +₩158.4b | 85.6% | PS49.8x |